Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease

BACKGROUND: Molecular therapies and precision medicine are expected to be developed for liver cancer based on the diagnosis of DNA somatic alterations. However, it remains unclear whether TERT promoter mutation (TERT C228T) in serum cfDNA is useful for the diagnosis of liver cancer with non-viral fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Akuta, Norio, Kawamura, Yusuke, Suzuki, Fumitaka, Kobayashi, Mariko, Arase, Yasuji, Saitoh, Satoshi, Muraishi, Nozomu, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Suzuki, Yoshiyuki, Ikeda, Kenji, Kumada, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013341/
https://www.ncbi.nlm.nih.gov/pubmed/35306637
http://dx.doi.org/10.1007/s12072-022-10313-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013341/
https://www.ncbi.nlm.nih.gov/pubmed/35306637
http://dx.doi.org/10.1007/s12072-022-10313-y

Ejemplares similares